{"title":"钙通道Orai3参与非小细胞肺癌(NSCLC)顺铂化疗耐药","authors":"Rédoane Daoudi","doi":"arxiv-2307.10289","DOIUrl":null,"url":null,"abstract":"This is the second part of the previous review. In the previous review we\nsuspected that Orai3 channels were involved in lung cancer and more precisely\nin several cancers. Here we confirm that calcium dysregulation is important for\ncancer development. in this paper we show that Orai3 is an upstream activator\nof AKT and we prove that AKT is involved in chemoresistance in NSCLC.","PeriodicalId":501170,"journal":{"name":"arXiv - QuanBio - Subcellular Processes","volume":"58 52","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Involvement of calcium channels Orai3 in the chemoresistance to cisplatin in non-small cell lung cancer (NSCLC)\",\"authors\":\"Rédoane Daoudi\",\"doi\":\"arxiv-2307.10289\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This is the second part of the previous review. In the previous review we\\nsuspected that Orai3 channels were involved in lung cancer and more precisely\\nin several cancers. Here we confirm that calcium dysregulation is important for\\ncancer development. in this paper we show that Orai3 is an upstream activator\\nof AKT and we prove that AKT is involved in chemoresistance in NSCLC.\",\"PeriodicalId\":501170,\"journal\":{\"name\":\"arXiv - QuanBio - Subcellular Processes\",\"volume\":\"58 52\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"arXiv - QuanBio - Subcellular Processes\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/arxiv-2307.10289\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"arXiv - QuanBio - Subcellular Processes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/arxiv-2307.10289","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Involvement of calcium channels Orai3 in the chemoresistance to cisplatin in non-small cell lung cancer (NSCLC)
This is the second part of the previous review. In the previous review we
suspected that Orai3 channels were involved in lung cancer and more precisely
in several cancers. Here we confirm that calcium dysregulation is important for
cancer development. in this paper we show that Orai3 is an upstream activator
of AKT and we prove that AKT is involved in chemoresistance in NSCLC.